中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
40期
2815-2818
,共4页
林辛锋%王群%白春学%洪群英
林辛鋒%王群%白春學%洪群英
림신봉%왕군%백춘학%홍군영
肺疾病,慢性阻塞性%肺肿瘤%诊断
肺疾病,慢性阻塞性%肺腫瘤%診斷
폐질병,만성조새성%폐종류%진단
Pulmonary disease,chronic obstructive%Lung neoplasms%Diagnosis
目的 调查非呼吸科医师对肺癌合并慢性阻塞性肺疾病(COPD)患者的诊断治疗情况,以促进其规范诊治.方法 回顾性调查2009年1月至2010年12月在复旦大学附属中山医院非呼吸科(主要为胸外科)住院的肺癌合并COPD患者,收集其出入院资料,分析一般情况、肺功能检查结果以及治疗情况.结果 非呼吸科接诊的肺癌合并COPD患者共240例,有COPD诊断者5例(2.1%).稳定期患者210例,按照2010年GOLD指南规范用药的共计50例(23.8%);急性加重期患者30例,有选择支气管扩张剂的13例(43.3%),选择抗生素的26例(86.7%),选择应用糖皮质激素的1例(3.3%).结论 非呼吸科对肺癌合并COPD患者的COPD漏诊情况严重,治疗不充分、不规范.
目的 調查非呼吸科醫師對肺癌閤併慢性阻塞性肺疾病(COPD)患者的診斷治療情況,以促進其規範診治.方法 迴顧性調查2009年1月至2010年12月在複旦大學附屬中山醫院非呼吸科(主要為胸外科)住院的肺癌閤併COPD患者,收集其齣入院資料,分析一般情況、肺功能檢查結果以及治療情況.結果 非呼吸科接診的肺癌閤併COPD患者共240例,有COPD診斷者5例(2.1%).穩定期患者210例,按照2010年GOLD指南規範用藥的共計50例(23.8%);急性加重期患者30例,有選擇支氣管擴張劑的13例(43.3%),選擇抗生素的26例(86.7%),選擇應用糖皮質激素的1例(3.3%).結論 非呼吸科對肺癌閤併COPD患者的COPD漏診情況嚴重,治療不充分、不規範.
목적 조사비호흡과의사대폐암합병만성조새성폐질병(COPD)환자적진단치료정황,이촉진기규범진치.방법 회고성조사2009년1월지2010년12월재복단대학부속중산의원비호흡과(주요위흉외과)주원적폐암합병COPD환자,수집기출입원자료,분석일반정황、폐공능검사결과이급치료정황.결과 비호흡과접진적폐암합병COPD환자공240례,유COPD진단자5례(2.1%).은정기환자210례,안조2010년GOLD지남규범용약적공계50례(23.8%);급성가중기환자30례,유선택지기관확장제적13례(43.3%),선택항생소적26례(86.7%),선택응용당피질격소적1례(3.3%).결론 비호흡과대폐암합병COPD환자적COPD루진정황엄중,치료불충분、불규범.
Objective To assess the diagnostic and therapeutic status of non-respiratory physicians managing chronic obstructive pulmonary disease(COPD)for patients with lung cancer at general hospitals to promote a standardized regimen.Methods Through a retrospective survey from January 2009 to December 2010 at our hospital,the data of clinical features,pulmonary function test results and information of therapy for lung cancer patients with COPD admitted at non-respiratory departments(mostly of thoracic surgery)were collected.Results A total of 240 lung cancer patients with COPD were admitted.Five patients were diagnosed as COPD with a diagnostic rate of 2.1%.And 210 cases of patients were stable.According to GOLD guidelines in 2010,only 50 cases were treated with adequate drugs(23.8%).Among another 30 patients with acute exacerbation,the following therapies were administrated:selective bronchodilator(n =13,43.3%),antibiotics(n=26,86.7%)and glucocorticoids(n=1,3.3%).Conclusion Underdiagnosis and inadequate treatment of COPD in lung cancer patients by non-respiratory physicians are too serious to be neglected.